Ophthalmic Complications Associated With Semaglutide and Tirzepatide

Ophthalmic Complications Associated With Sema...

Up next

Geographic Atrophy Enlargement Rates in the AREDS2 Study

Interview with Tiarnán D. L. Keenan, BM BCh, PhD, author of Modest and Variable Correlations Between Geographic Atrophy Enlargement Rates in Fellow Eyes in the AREDS2 Study. Hosted by Neil Bressler, MD. Related Content: Modest and Variable Correlations Between Geographic Atrophy ...  Show more

Prevalence and Health Care Disparities of Retinal Conditions

Interview with T. Y. Alvin Liu, MD, author of Prevalence and Health Care Disparities of Retinal Conditions: A Meta-Analysis. Hosted by Neil Bressler, MD. Related Content: Prevalence and Health Care Disparities of Retinal Conditions 

Recommended Episodes

Epidural Patching Outcomes and Predictors of Benefit in Patients With Suspected CSF Leak
Neurology Minute

Dr. Jessica Ailani and Dr. Ian Carroll discuss intracranial hypotension, the challenges of diagnosing and treating patients with CSF leaks, and the study's findings. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209449   This podcast is sponsored by argenx. V ...  Show more

Epidural Patching Outcomes and Predictors of Benefit in Patients With Suspected CSF Leak
Neurology® Podcast

Dr. Jessica Ailani talks with Dr. Ian Carroll about intracranial hypotension, the challenges of diagnosing and treating patients with CSF leaks, and the study's findings. Read the related article in Neurology.  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for mor ...  Show more

GLP-1 Receptor Agonists and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
JAMA Internal Medicine Author Interviews

Interview with Fasiha Kanwal, MD, MSHS, author of GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Hosted by Eve Rittenberg, MD, and Grace Yuan Zhang, MD Related Content: GLP-1 Rece ...  Show more

The Combination of Atomoxetine and Oxybutynin Greatly Reduces OSA Severity
Out of the Blue: An AJRCCM Podcast

Dr. John Fleetham is joined by Luigi Taranto Montemurro, MD, Andrew Wellman, MD, PhD, and Seva Polotsky, MD, PhD to discuss the impact the combination of Atomoxetine and Oxybutynin has on reducing the severity of obstructive sleep apnea.